Literature DB >> 34864426

Breast imaging: Beyond the detection.

Francesca Galati1, Giuliana Moffa2, Federica Pediconi3.   

Abstract

Breast cancer is a heterogeneous disease nowadays, including different biological subtypes with a variety of possible treatments, which aim to achieve the best outcome in terms of response to therapy and overall survival. In recent years breast imaging has evolved considerably, and the ultimate goal is to predict these strong phenotypic differences noninvasively. Indeed, breast cancer multiparametric studies can highlight not only qualitative imaging parameters, as the presence/absence of a likely malignant finding, but also quantitative parameters, suggesting clinical-pathological features through the evaluation of imaging biomarkers. A further step has been the introduction of artificial intelligence and in particular radiogenomics, that investigates the relationship between breast cancer imaging characteristics and tumor molecular, genomic and proliferation features. In this review, we discuss the main techniques currently in use for breast imaging, their respective fields of use and their technological and diagnostic innovations.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Artificial intelligence; Automated breast ultrasound; Contrast-enhanced mammography; Digital breast tomosynthesis; Magnetic resonance imaging; Radionuclide breast imaging

Mesh:

Year:  2021        PMID: 34864426     DOI: 10.1016/j.ejrad.2021.110051

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  2 in total

Review 1.  MRI as a biomarker for breast cancer diagnosis and prognosis.

Authors:  Francesca Galati; Veronica Rizzo; Rubina Manuela Trimboli; Endi Kripa; Roberto Maroncelli; Federica Pediconi
Journal:  BJR Open       Date:  2022-05-26

Review 2.  Ultrasound radiomics in personalized breast management: Current status and future prospects.

Authors:  Jionghui Gu; Tian'an Jiang
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.